Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP220312.RADuZZrlSjNPRuAJByK8Mmsfukod0TeOlM6BrH2wc0-ag130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP220312.RADuZZrlSjNPRuAJByK8Mmsfukod0TeOlM6BrH2wc0-ag130_assertion type Assertion NP220312.RADuZZrlSjNPRuAJByK8Mmsfukod0TeOlM6BrH2wc0-ag130_head.
- NP220312.RADuZZrlSjNPRuAJByK8Mmsfukod0TeOlM6BrH2wc0-ag130_assertion description "[Whereas the short (p73beta) isoform accounted for 20-25% of the total p73 mRNA in most of the tumors, these splicing characteristics were altered in ependymomas (only 9% of p73beta) and in neurinomas (up to 53% of p73beta).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP220312.RADuZZrlSjNPRuAJByK8Mmsfukod0TeOlM6BrH2wc0-ag130_provenance.
- NP220312.RADuZZrlSjNPRuAJByK8Mmsfukod0TeOlM6BrH2wc0-ag130_assertion evidence source_evidence_literature NP220312.RADuZZrlSjNPRuAJByK8Mmsfukod0TeOlM6BrH2wc0-ag130_provenance.
- NP220312.RADuZZrlSjNPRuAJByK8Mmsfukod0TeOlM6BrH2wc0-ag130_assertion SIO_000772 10213163 NP220312.RADuZZrlSjNPRuAJByK8Mmsfukod0TeOlM6BrH2wc0-ag130_provenance.
- NP220312.RADuZZrlSjNPRuAJByK8Mmsfukod0TeOlM6BrH2wc0-ag130_assertion wasDerivedFrom befree-20140225 NP220312.RADuZZrlSjNPRuAJByK8Mmsfukod0TeOlM6BrH2wc0-ag130_provenance.
- NP220312.RADuZZrlSjNPRuAJByK8Mmsfukod0TeOlM6BrH2wc0-ag130_assertion wasGeneratedBy ECO_0000203 NP220312.RADuZZrlSjNPRuAJByK8Mmsfukod0TeOlM6BrH2wc0-ag130_provenance.